New Diabetes Drug May Increase Risk of Breast, Bladder Cancer: FDA
A new diabetes drug being developed by Bristol-Myers Squibb and AstraZeneca could be derailed by increased risks of bladder cancer and breast cancer.
Tag Archives: Bristol Myer Squibb
-
-
Value of Plavix Genetic Test to Avoid Heart Risk Questioned
The results of two new studies are raising questions about the value of requiring patients to undergo a genetic test to see whether the blood thinner Plavix will be effective…
-
Coumadin Recall Issued Over Questionable Ingredient in Blood Clot Drug
Uncertainty about the quality of a key ingredient in Coumadin has led to a recall of eight lots of the widely used blood thinner, which is used to reduce the…
-
Plavix Lawsuits Moving Forward Towards Trial
After months of delay awaiting a Supreme Court decision about whether FDA approval preempts cases against drug makers for failing to warn about dangerous side effects, a U.S. District Judge…
